Team:WashU/Characterization
From 2012.igem.org
(Difference between revisions)
(8 intermediate revisions not shown) | |||
Line 1: | Line 1: | ||
- | {{ | + | {{WashUbackSaffron}} |
{{WashUprojectbar}} | {{WashUprojectbar}} | ||
<html> | <html> | ||
<body> | <body> | ||
<div id = "zconstructchar"> | <div id = "zconstructchar"> | ||
- | <marquee behavior="scroll" direction="left" scrollamount="10"> | + | <marquee behavior="scroll" direction="left" scrollamount="10"><h1>Phase I</h1></marquee> |
- | <h1> | + | Saffron in a Kan is focused on the modification of carotenoids to produce compounds characteristic of saffron. The first step to doing this is optimizing the production of the carotenoid precursor, zeaxanthin, in our target species. Below you will find our work for both <i>Synechocystis</i> and <i>E. coli</i>. |
+ | <h1>Synechocystis</h1> | ||
+ | To see if <i>Synechocystis</i> was a viable chassis organism for production of crocin and safranal we wrote a flux balance analysis model to predict theoretical yield of these two compounds. As a first step, we wanted to predict the optimal conditions for the maximum production of zeaxanthin. Below is a phenotypic phase plane for the production of zeaxanthin under varying carbon dioxide and photon fluxes. The technical detials can be found on our modeling page. | ||
+ | <img src = "http://dl.dropbox.com/u/88390549/zeaxanthin.png" width="785"> | ||
+ | <h1>E. coli</h1> | ||
<p> | <p> | ||
- | + | Thankfully, Tokyo Tech developed a biobrick which contains all the enzymes necessary to produce zeaxanthin in <i>E. coli</i>, <a href="http://partsregistry.org/Part:BBa_K395704">BBa_395704</a>. This is an enormous help in advancing our project, however the biobrick lacked the characterization needed for optimal production of zeaxanthin through utilization of its inducible promoters. | |
<br><br> | <br><br> | ||
To this aim, we further charcterized this part for both our project and for furture teams working on a developing biobricks that depend on the synthesis of zeaxanthin <i>in vivo</i>. <br><br> | To this aim, we further charcterized this part for both our project and for furture teams working on a developing biobricks that depend on the synthesis of zeaxanthin <i>in vivo</i>. <br><br> | ||
- | < | + | <h4>Optimization of induction conditions</h4> |
The construct that Tokyo Tech built is composed of two parts: <br> | The construct that Tokyo Tech built is composed of two parts: <br> | ||
1. CrtZ which is needed to cleave beta-carotene into zeaxanthin. This component is repressed in the presence of glucose and <br> induced in the presence of arabanose through a pbad/arac promoter. <br> | 1. CrtZ which is needed to cleave beta-carotene into zeaxanthin. This component is repressed in the presence of glucose and <br> induced in the presence of arabanose through a pbad/arac promoter. <br> | ||
Line 23: | Line 27: | ||
<br> | <br> | ||
- | While growth rate is important for the successful production of our target compounds, what is more important is the net amount of zeaxanthin made by the cells. To measure this we let the cells grow for 14hrs, towards the end of log phase, and measured cell denisty and amount of carotenoid produced. The total carotenoids produced was measured by extracting pigments for a set volume of cells and measuring their absorbance at 450. | + | While growth rate is important for the successful production of our target compounds, what is more important is the net amount of zeaxanthin made by the cells. To measure this we let the cells grow for 14hrs, towards the end of log phase, and measured cell denisty and amount of carotenoid produced. The total carotenoids produced was measured by extracting pigments for a set volume of cells and measuring their absorbance at 450. From this number we were able to calculate an approximate number of molecules of zeaxanthin produced per cell. |
<br><br> | <br><br> | ||
</p> | </p> | ||
Line 29: | Line 33: | ||
<img src="https://static.igem.org/mediawiki/2012/6/68/Presentation1.jpg" width=790 div align="middle"/><br><br><br> | <img src="https://static.igem.org/mediawiki/2012/6/68/Presentation1.jpg" width=790 div align="middle"/><br><br><br> | ||
</div> | </div> | ||
- | |||
</html> | </html> |
Latest revision as of 23:25, 19 September 2012